ACSS2 and hepatocellular carcinoma: The loss of ACSS2 reduces the tumor burden of hepatocellular carcinomas in mice [7,10]; in mice with ACSS2-positive hepatocellular carcinoma, liver tumors grew faster and were more aggressive [7].